Madrigal Pharmaceuticals Inc (MDGL)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$551.95

Buy

$558.81

arrow-down$-5.99 (-1.07%)

Prices updated at 16 Dec 2025, 15:23 EST

Prices minimum 15 mins delay

Prices in USD

Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH).

NASDAQ

-0.01%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$559.99 - $549.66
	$605.00 - $265.00
	-
	12,730.89m
	-
	-
	11,854
	20.35
	366,726.83
	-3.20
	22.00m
	US5588681057
	-12.91
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.